Tic hydantoin sigma-1 agonist: Pharmacological characterization on cocaine-induced stimulant and appetitive effects

European Neuropsychopharmacology

Volumn 19, Issue 7, 2009, Pages 504-515

  Toussaint, Marion ^a   Delair, Brice ^b,c,d   Foulon, Catherine ^e   Lempereur, Nadège ^b,c,d   Vaccher, Claude ^e   Maurice, Tangui ^b,c,d   Melnyk, Patricia ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b University of Montpellier   (France)

^c UNIV MONTPELLIER   (France)

^d PSL RESEARCH UNIVERSITY   (France)

^e UNIV LILLE   (France)

Author keywords

Cocaine addiction; ; Drug design; ; Hydantoin; ; Sigma receptor; ; Tetrahydroisoquinoline

Indexed keywords

2 [3 (BENZYL METHYL AMINO) PROPYL] 10,10A DIHYDRO 5H IMIDAZO[1,5 B]ISOQUINOLINE 1,3 DIONE; COCAINE; HYDANTOIN DERIVATIVE; PSYCHOSTIMULANT AGENT; TIC HYDANTOIN SIGMA 1 AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APPETITE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DESIGN; DRUG INHIBITION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; LOCOMOTION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; APPETITIVE BEHAVIOR; BEHAVIOR, ANIMAL; CELLULOSE, OXIDIZED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; ENZYME INHIBITORS; ETHYLENEDIAMINES; EXTINCTION, PSYCHOLOGICAL; HYDANTOINS; HYPERKINESIS; LOCOMOTION; MALE; MICE; PROTEIN BINDING; RECEPTORS, SIGMA; TIME FACTORS;

EID: 67349088727     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2009.01.008     Document Type: Article

References (45)

1. Ablordeppey S.Y., Fischer J.B., Law H., and Glennon R.A. Probing the proposed phenyl-A region of the sigma-1 receptor. Bioorg. Med. Chem. 10 (2002) 2759-2765
2. Alonso G., Phan V.L., Guillemain I., Saunier M., Legrand A., Anoal M., and Maurice T. Immunocytochemical localization of the sigma1 receptor in the adult rat central nervous system. Neuroscience 97 (2000) 155-170
3. Banker M.J., Clark T.H., and Williams J.A. Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding. J. Pharm. Sci. 92 (2003) 967-974
4. Bowen W.D., de Costa B.R., Hellewell S.B., Walker M., and Rice K.C. [3H](+)-pentazocine: a potent and highly selective benzomorphan-based probe for sigma1 receptors. Mol. Neuropharmacol. 3 (1993) 117-126
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
6. Cazenave-Gassiot A., Charton J., Girault-Mizzi S., Gilleron P., Debreu-Fontaine M.-A., Sergheraert C., and Melnyk P. Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective σ1 ligands. Part 2. Bioorg. Med. Chem. Lett. 15 (2005) 4828-4832
7. Charton J., Cazenave Gassiot A., Girault-Mizzi S., Debreu-Fontaine M.-A., Melnyk P., and Sergheraert C. Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective σ1 ligands. Part 1. Bioorg. Med. Chem. Lett. 15 (2005) 4833-4837
8. Crespi C.L., Miller V., and Penman B. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Anal. Biochem. 248 (1997) 188-190
9. Dackis C.A. Recent advances in the pharmacotherapy of cocaine dependence. Curr. Psychiatry Rep. 6 (2004) 323-331
10. Doron R., Fridman L., Gispan-Herman I., Maayan R., Weizman A., and Yadid G. DHEA, a neurosteroid, decreases cocaine self-administration and reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 31 (2006) 2231-2236
11. Ganapathy M.E., Prasad P.D., Huang W., Seth P., Leibach F.H., and Ganapathy V. Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line. J. Pharmacol. Exp. Ther. 289 (1999) 251-260
12. Glennon R.A. Pharmacophore identification for sigma-1 (σ1) receptor binding: application of the "deconstruction-reconstruction-elaboration" approach. Mini-Rev. Med. Chem. 5 (2005) 927-940
13. Gres M.C., Julian B., Bourrie M., Meunier V., Roques C., Berger M., Boulenc X., Berger Y., and Fabre G. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm. Res. 15 (1998) 726-733
14. Hayashi T., and Su T.P. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival. Cell 131 (2007) 596-610
15. Hayashi T., Maurice T., and Su T.P. Ca2+ signaling via sigma1-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration. J. Pharmacol. Exp. Ther. 293 (2000) 788-798
16. Itzhak Y., and Martin J.L. Cocaine-induced conditioned place preference in mice: Induction, extinction and reinstatement by related psychostimulants. Neuropsychopharmacology 26 (2002) 130-134
17. Karila L., Gorelick D., Weinstein A., Noble F., Benyamina A., Coscas S., Blecha L., Lowenstein W., Martinot J.L., Reynaud M., and Lépine J.P. New treatments for cocaine dependence: a focused review. Int. J. Neuropsychopharmacol. 11 (2008) 425-438
18. Koob G.F., and Nestler E.J. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9 (1997) 482-497
19. Kuhnz W., and Gieschen H. Predicting the oral bioavailability of 19-nortestosterone progestins in vivo from their metabolic stability in human liver microsomal preparations in vitro. Drug Metab. Dispos. 26 (1998) 1120-1127
20. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46 (1997) 3-26
21. Maayan R., Lotan S., Doron R., Shabat-Simon M., Gispan-Herman I., Weizman A., and Yadid G. Dehydroepiandrosterone (DHEA) attenuates cocaine-seeking behavior in the self-administration model in rats. Eur. Neuropsychopharmacol. 16 (2006) 329-339
22. Martin-Fardon R., Maurice T., Aujla H., Bowen W.D., and Weiss F. Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. Neuropsychopharmacology 32 (2007) 1967-1973
23. Matsumoto R.R., McCracken K.A., Pouw B., Miller J., Bowen W.D., Williams W., and De Costa B.R. N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice. Eur. J. Pharmacol. 411 (2001) 261-276
24. Maurice T., Martin-Fardon R., Romieu P., and Matsumoto R.R. Sigma1 receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci. Biobehav. Rev. 26 (2002) 499-527
25. McCracken K.A., Bowen W.D., de Costa B.R., and Matsumoto R.R. Two novel sigma receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity. Eur. J. Pharmacol. 370 (1999) 225-232
26. Menkel M., Terry M., Portecorvo M., Katz J.L., and Witkin J.M. Selective sigma ligands block stimulant effects of cocaine. Eur. J. Pharmacol. 201 (1991) 251-252
27. Monnet F.P., Blier P., Debonnel G., and De Montigny C. Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency. Naunyn-Schmiedeberg's Arch. Pharmacol. 346 (1992) 32-39
28. Morin-Surun M.P., Collin T., Denavit-Saubié M., Baulieu E.E., and Monnet F.P. Intracellular sigma1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 8196-8199
29. Mueller D., and Stewart J. Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction. Behav. Brain Res. 11 (2000) 39-47
30. Newman A.H. Novel pharmacotherapies for cocaine abuse 1997-2000. Expert Opin. Ther. Pat. 10 (2000) 1095-1122
31. Ono S., Hatanaka T., Hatta H., Satoh T., Gonzalez F., and Tsutsui M. Specificity of substrate and inhibitor probes for cytochromes P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 26 (1996) 681-693
32. Preti A. New developments in the pharmacotherapy of cocaine abuse. Addict Biol. 12 (2007) 133-151
33. Ritz M.C., Lamb R.J., Goldberg S.R., and Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 (1987) 1219-1223
34. Romieu P., Martin-Fardon R., and Maurice T. Involvement of the σ1 receptor in the cocaine-induced conditioned place preference. Neuroreport 11 (2000) 2885-2888
35. Romieu P., Phan V.L., Martin-Fardon R., and Maurice T. Involvement of the σ1 receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Neuropsychopharmacology 26 (2002) 444-455
36. Romieu P., Martin-Fardon R., Bowen W.B., and Maurice T. σ1 Receptor-related neuroactive steroids modulate cocaine-induced reward. J. Neurosci. 23 (2003) 3572-3576
37. Romieu P., Meunier J., Garcia D., Zozime N., Martin-Fardon R., Bowen W.D., and Maurice T. The sigma1 (σ1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming. Psychopharmacology 175 (2004) 154-162
38. Sangster J. Wiley Series in Solution Chemistry vol. 2 (1997), John Wiley and Sons
39. Skuza G. Effect of sigma ligands on the cocaine-induced convulsions in mice. Pol. J. Pharmacol. 51 (1999) 477-483
40. Soares B.G., Lima M.S., Reisser A.A., and Farrell M. Dopamine agonists for cocaine dependence. Cochrane Database Syst Rev. 2 (2003) CD003352
41. Stefanski R., Justinova Z., Hayashi T., Takebayashi M., Goldberg S.R., and Su T.P. Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls. Psychopharmacology 175 (2004) 68-75
42. Stresser D.M., Blanchard A.P., Turner S.D., Erve J.C., Dandeneau A.A., Miller V.P., and Crespi C.L. Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorimetric substrates. Drug Metab. Dispos. 28 (2000) 1440-1448
43. Ujike H., Kuroda S., and Otsuki S. Sigma receptor antagonists block the development of sensitization to cocaine. Eur. J. Pharmacol. 296 (1996) 123-128
44. Warner E.A. Cocaine abuse. Ann. Intern. Med. 119 (1993) 226-235
45. Zhou S.F. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr. Drug Metab. 9 (2008) 310-322